OnKure Therapeutics, Inc. is projected to rise to $5.12 by 2027, a +22% move from its current price of $4.20. OKUR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.07 | $4.20 | $4.32 | +0.01% |
| Jul 14 | $4.03 | $4.20 | $4.37 | +0.03% |
| Jul 15 | $3.99 | $4.20 | $4.42 | +0.04% |
| Jul 16 | $3.96 | $4.20 | $4.45 | +0.05% |
| Jul 17 | $3.93 | $4.20 | $4.48 | +0.07% |
| Jul 18 | $3.91 | $4.20 | $4.51 | +0.08% |
| Jul 19 | $3.88 | $4.20 | $4.54 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.88 | $4.20 | $4.54 | +0.09% |
| Week 2 | $3.76 | $4.20 | $4.69 | +0.18% |
| Week 3 | $3.68 | $4.21 | $4.81 | +0.27% |
| Week 4 | $3.60 | $4.21 | $4.92 | +0.37% |
| Week 5 | $3.54 | $4.21 | $5.01 | +0.46% |
| Week 6 | $3.49 | $4.22 | $5.10 | +0.55% |
| Week 7 | $3.44 | $4.22 | $5.19 | +0.64% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate is OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation, which is in Phase 1 clinical trial for solid tumors, including breast cancer.
Founded in 2011 and headquartered in Boulder, Colorado, the company operates within the Healthcare category.
OnKure Therapeutics, Inc. (OKUR) is currently priced at $4.44 with a market capitalization of $179.36M and is ranked 3661 by market cap.
The forecast shows a path of potential upside, beginning with 2026 where min is $2.32, avg is $4.44, and max is $6.20, and evolving to higher levels in later years.
From 2027 onward, the sentiment is BULLISH in the forecast, with rising averages through 2035 and beyond. The projected figures culminate in a 2050 average of $50.80 and a max near $99.93, with a long-run ROI of 1044.2%.
A major floor 29.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 9.7% above — a clean break opens room to run.
A major ceiling 25.6% above — clearing it would confirm fresh momentum.
Key OKUR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OKUR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.44 | Sell | $4.41 | Sell |
| MA 10 | $4.48 | Sell | $4.42 | Sell |
| MA 20 | $4.38 | Sell | $4.38 | Sell |
| MA 50 | $4.19 | Buy | $4.25 | Sell |
| MA 100 | $4.02 | Buy | $4.01 | Buy |
| MA 200 | $3.46 | Buy | $4.03 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.73 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -56.33 | Neutral |
| Williams %R (14) | -80.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 1.90 | Buy |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 20.00 | Neutral |
| TRIX (15) | 0.31 | Buy |
| Awesome (5,34) | 0.13 | Buy |
| Ultimate (7,14,28) | 37.94 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 4.38 | Sell |
| ADX (14) | 11.93 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture places the stock in a defined near-term range. The 30-day range is $3.60 to $5.48, and the current price is $4.44.
The stock trades above the SMA50 of $4.28 and the SMA200 of $3.34, consistent with positive near-term momentum. RSI(14) sits at 60, indicating room to move higher before becoming overbought.
Near-term support sits at $3.08 and resistance at $4.48, anchoring the immediate trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.32 | $4.20 | $5.55 | 0% | Neutral | |
| $4.05 | $5.12 | $6.88 | +22% | Bullish | |
| $4.79 | $6.25 | $8.72 | +49% | Bullish | |
| $5.57 | $7.44 | $10.71 | +77% | Bullish | |
| $6.41 | $8.77 | $12.95 | +109% | Bullish | |
| $6.16 | $8.59 | $12.98 | +105% | Bullish | |
| $6.15 | $8.74 | $13.47 | +108% | Bullish | |
| $7.12 | $10.30 | $16.17 | +146% | Bullish | |
| $7.86 | $11.57 | $18.47 | +176% | Bullish | |
| $9.39 | $14.05 | $22.78 | +235% | Bullish | |
| $11.16 | $17.99 | $31.12 | +329% | Bullish | |
| $20.66 | $37.86 | $71.99 | +803% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.32 | $4.20 | $4.88 | +0.00% |
| August 2026 | $3.43 | $4.06 | $4.93 | -3.31% |
| September 2026 | $3.56 | $4.25 | $5.23 | +4.66% |
| October 2026 | $3.60 | $4.31 | $5.36 | +1.61% |
| November 2026 | $3.53 | $4.26 | $5.34 | -1.22% |
| December 2026 | $3.63 | $4.40 | $5.55 | +3.17% |
Click any year to see its month-by-month OKUR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OKUR is projected to trade between $2.32 and $5.55, averaging $4.20 — a potential gain of 0% from today's $4.20. Price action looks broadly range-bound.
OnKure Therapeutics, Inc.'s 2027 outlook centres on $5.12, within a $4.05 to $6.88 range. That is up +22% on the projected 2026 average. That marks a +22% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, OKUR could reach as high as $8.72, with a base case around $6.25 and support toward $4.79 — roughly +49% from $4.20. Momentum favours further upside here.
Expect OKUR to range from $5.57 to $10.71 through 2029. The $7.44 average target implies a +77% move from current prices. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The OKUR price prediction for 2030 points to an average of $8.77 (low $6.41, high $12.95) — a potential gain of +109% on today's $4.20. Momentum favours further upside here.
In 2031, OKUR is projected to trade between $6.16 and $12.98, averaging $8.59 — a potential gain of +105% from today's $4.20. That is -2% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
OnKure Therapeutics, Inc.'s 2032 outlook centres on $8.74, within a $6.15 to $13.47 range. That is up +2% on the projected 2031 average. That marks a +108% change versus current levels. Momentum favours further upside here.
By 2033, OKUR could reach as high as $16.17, with a base case around $10.30 and support toward $7.12 — roughly +146% from $4.20. Buyers look set to stay in control over this stretch.
Expect OKUR to range from $7.86 to $18.47 through 2034. The $11.57 average target implies a +176% move from current prices. That is up +12% on the projected 2033 average. Momentum favours further upside here.
The OKUR price prediction for 2035 points to an average of $14.05 (low $9.39, high $22.78) — a potential gain of +235% on today's $4.20. Buyers look set to stay in control over this stretch.
In 2040, OKUR is projected to trade between $11.16 and $31.12, averaging $17.99 — a potential gain of +329% from today's $4.20. That is up +28% on the projected 2035 average. Momentum favours further upside here.
OnKure Therapeutics, Inc.'s 2050 outlook centres on $37.86, within a $20.66 to $71.99 range. That is up +111% on the projected 2040 average. That marks a +803% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in OKUR today (≈ 238.379023 OKUR) could be worth
$9,026.18
+$8,026.18 (+803%) by 2050 · US Dollar
Based on the average projected OKUR price of $37.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OKURwould be worth at today's price.
$1,000 invested in OKUR on Jul 10, 2025 (≈ 392.15687 OKUR) would be worth
$1,645.1
+$645.1 (+64.5%) today · 1.65× · US Dollar
Based on a OKUR entry price of $2.55 vs. today's $4.2.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.58 | $915.94 | -8.4% |
| 1 month ago | $4.19 | $1,001.19 | +0.1% |
| 3 months ago | $4.3 | $975.58 | -2.4% |
| 6 months ago | $3.21 | $1,306.85 | +30.7% |
| 1 year ago | $2.55 | $1,645.1 | +64.5% |
| All time (5.0y) ago | $90.1 | $46.56 | -95.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OKUR forecast.
Our base-case forecast reaches $8.40 around 2030.
Implied market cap at $8.40: $339.32M
The multi-year forecast envisions a meaningful rise in average price over time. The 2026 average is $4.44, rising to $10.12 by 2030, and reaching $50.80 on average by 2050.
Forecasted ROI climbs from 25.1% in 2027 to 127.9% in 2030, 300.6% by 2035, 428.9% by 2040, and 1044.2% by 2050, with a bullish sentiment pattern across the horizon.
These figures reflect estimates for the asset and are not guaranteed. While the outlook shows substantial upside, outcomes depend on market conditions and other factors outside the numbers provided.
Tap a question to reveal the answer.
2030 average: $10.12; min: $7.27; max: $15.24; ROI: 127.9%; sentiment: BULLISH.
Forecast shows sentiment turning BULLISH from 2027 onward with rising averages through 2050 (average $50.80 by 2050; 2026 average $4.44). Note these are estimates, not guarantees.
The 2050 max forecast is $99.93, which is just under $100.
Current price: $4.44. Market cap: $179.36M.
30-day range: $3.60 to $5.48. Near-term support: $3.08. Near-term resistance: $4.48.
OnKure Therapeutics, Inc. Community Discussion
0Share your OnKure Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.